In this study, we performed an integrative pan-cancer investigation of CCT4 across 33 tumor types, leveraging publicly available transcriptomic, proteomic, genomic, and immunologic datasets from The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), and complementary repositories. This evidence concerns the gene CCT4 and neoplasm.